Baird, DT, Factors regulating the growth of the preovulatory follicle in the sheep and human, J Reprod Fertil. 1983, 69, 343–52.Google Scholar

Wallace, WH, Kelsey, TW, Human ovarian reserve from conception to the menopause, PLoS One, 2010, 8772.CrossRefGoogle Scholar

Fauser, BC, Van Heusden, AM, Manipulation of human ovarian function: physiological concepts and clinical consequences, Endocr Rev. 1997, 18, 71–106.Google ScholarPubMed

Nelson, SM, Yates, RW, Fleming, R, Serum anti-Müllerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles–implications for individualization of therapy, Hum Reprod. 2007, 22, 2414–21.CrossRefGoogle ScholarPubMed

de Ziegler, D, Gayet, V, Aubriot, FX et al., Use of oral contraceptives in women with endometriosis before assisted reproduction treatment improves outcomes, Fertil Steril. 2010, 94, 2796–9.Google Scholar

Porchet, HC, Le Cotonnec, JY, Loumaye, E, Clinical pharmacology of recombinant human follicle stimulating hormone (FSH). III. Pharmacokinetic-pharmacodynamic modeling after repeated subcutaneous administration, Fertil Steril. 1994, 61, 687–95.Google Scholar

Olivennes, F, Trew, G, Borini, A et al., Randomized, controlled, open-label, non-inferiority study of the CONSORT algorithm for individualized dosing of follitropin alfa, Reprod Biomed Online. 2015, 30, 248–57.Google Scholar

Jayaprakasan, K, Hopkisson, J, Campbell, B et al., A randomised controlled trial of 300 versus 225 IU recombinant FSH for ovarian stimulation in predicted normal responders by antral follicle count, BJOG. 2010, 117, 853–62.Google Scholar

Schimberni, M, Ciardo, F, Schimberni, M et al., Short gonadotropin-releasing hormone agonist versus flexible antagonist versus clomiphene citrate regimens in poor responders undergoing in vitro fertilization: a randomized controlled trial, Eur Rev Med Pharmacol Sci. 2016, 20, 4354–61.Google Scholar

Wikland, M, Bergh, C, Borg, K et al., A prospective, randomized comparison of two starting doses of recombinant FSH in combination with cetrorelix in women undergoing ovarian stimulation for IVF/ICSI, Hum Reprod. 2001, 16, 1676–81.Google Scholar

La Marca, A, Grisendi, V, Giulini, S et al., Live birth rates in the different combinations of the Bologna criteria poor ovarian responders: a validation study, J Assist Reprod Genet. 2015, 32, 931–7.CrossRefGoogle ScholarPubMed

Nyboe Andersen, A, Nelson, SM, Fauser, BC et al., ESTHER-1 study group., Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial, Fertil Steril, 2016, [Epub ahead of print], PMID:27912901.Google Scholar

Olsson, H, Sandström, R, Grundemar, L, Different pharmacokinetic and pharmacodynamic properties of recombinant follicle-stimulating hormone (rFSH) derived from a human cell line compared with rFSH from a non-human cell line, J Clin Pharmacol. 2014, 54, 1299–307.Google Scholar

Sunkara, SK, Coomarasamy, A, Faris, R, Braude, P, Khalaf, Y, Long gonadotropin-releasing hormone agonist versus short agonist versus antagonist regimens in poor responders undergoing in vitro fertilization: a randomized controlled trial, Fertil Steril. 2014, 101, 147–53.CrossRefGoogle ScholarPubMed

Fleming, R, Yates, R, Coutts, JRT, Presented to the Endocrine Society annual meeting, 1994.Google Scholar

Fleming, R, Ambrose, P, Mitchell, P, Adam, C, Gaudoin, M, Manuscript in preparation.Google Scholar

Blockeel, C, Sterrenburg, MD, Broekmans, FJ et al., Follicular phase endocrine characteristics during ovarian stimulation and GnRH antagonist cotreatment for IVF: RCT comparing recFSH initiated on cycle day 2 or 5, J Clin Endocrinol Metab. 2011, 96, 1122–8.Google Scholar

Cédrin-Durnerin, I, Bständig, B, Parneix, I et al., Effects of oral contraceptive, synthetic progestogen or natural estrogen pre-treatments on the hormonal profile and the antral follicle cohort before GnRH antagonist protocol, Hum Reprod. 2007, 22, 109–16.Google Scholar

Griesinger, G, Kolibianakis, EM, Venetis, C, Diedrich, K, Tarlatzis, B, Oral contraceptive pretreatment significantly reduces ongoing pregnancy likelihood in gonadotropin-releasing hormone antagonist cycles: an updated meta-analysis, Fertil Steril. 2010, 94, 2382–4.Google Scholar

Sobotka, V, Streda, R, Mardesic, T, Tosner, J, Heracek, J, Steroids pretreatment in assisted reproduction cycles, J Steroid Biochem Mol Biol. 2014, 139, 114–21.Google Scholar

Griesinger, G, Venetis, CA, Tarlatzis, B, Kolibianakis, EM, To pill or not to pill in GnRH-antagonist cycles: the answer is in the data already!, Reprod Biomed Online. 2015, 31, 42588.CrossRefGoogle ScholarPubMed